<DOC>
	<DOCNO>NCT01170611</DOCNO>
	<brief_summary>This clinical investigation prospective , single-blinded , randomized trial . The primary objective concern safety effectiveness AAIsafeR mode preventive algorithm .</brief_summary>
	<brief_title>Prevention Atrial Arrhythmia Patients Without Atrioventricular ( AV ) Conduction Disease</brief_title>
	<detailed_description>In study , patient randomize DDD mode , AAIsafeR mode , AAIsafeR mode plus atrial arrhythmia preventive algorithm . The atrial arrhythmia ( AA ) burden serve primary measure effectiveness .</detailed_description>
	<mesh_term>Sick Sinus Syndrome</mesh_term>
	<criteria>A pacemaker indication sinus node dysfunction and/or bradytachy syndrome OR already implant less three month mention reason supply symphony 2550 DR time inclusion AND A PR interval &lt; 250ms AND Documented atrial arrhythmia past year Medication antiarrhythmic must stable least one month ( 2 month amiodarone ) prior enrollment Patients must less two known cardioversions within last year Patient sign consent form receive appropriate information Need replacement pacemaker device Have unknown PR interval Known AV block â‰¥ 250 m PR interval Minor and/or pregnant woman Patients enrol clinical trial Patients sustain ventricular arrhythmia Patients severe coronary artery disease ( discretion investigator ) Patients advanced cardiomyopathy ( discretion investigator ) Patients sustain myocardial infarction undergone cardiac surgery within past 30 day Patients unstable angina pectoris Patients whose life expectancy le 1 year Patients unlikely return require followup visit Patients present permanent atrial arrhythmia usually require cardioversion terminate arrhythmia and/or Patients whose physician plan add change medical treatment AA episodes followup period . Patient unable understand purpose study refuse cooperate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>